Skip to content
The Policy VaultThe Policy Vault

Depakote ECMedica

FDA-approved indications for divalproex sodium and valproic acid (seizure disorders, migraine prophylaxis, and bipolar disorder)

Preferred products

  • generic divalproex sodium capsules
  • generic divalproex sodium delayed-release tablets
  • generic divalproex sodium extended-release tablets
  • generic valproic acid capsules
  • generic valproic acid oral solution

Initial criteria

  • Patient has tried one Step 1 Product (generic divalproex sodium capsules, generic divalproex sodium delayed-release tablets, generic divalproex sodium extended-release tablets, generic valproic acid capsules, or generic valproic acid oral solution)

Approval duration

1 year